A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 304855)

Published in Proc Natl Acad Sci U S A on May 01, 1987

Authors

A A Creasey, R Yamamoto, C R Vitt

Articles citing this

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci U S A (1991) 3.76

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci U S A (1990) 3.59

The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A (1991) 3.40

Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol (1988) 2.66

Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med (1990) 2.02

Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C. J Exp Med (1991) 1.47

Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci U S A (1990) 1.40

Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes. Mol Cell Biol (1988) 1.35

Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med (1990) 1.33

Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators. J Exp Med (1987) 1.27

Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med (1989) 1.24

Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis. EMBO J (1991) 1.15

Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci U S A (1990) 1.08

Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha. Am J Pathol (1995) 0.87

Mitogenic signalling pathway of tumour necrosis factor involves the rapid tyrosine phosphorylation of 41,000-Mr and 43,000-Mr cytosol proteins. Biochem J (1990) 0.86

Density Gradient Study of Victorin-Binding Proteins in Oat (Avena sativa) Cells. Plant Physiol (1993) 0.80

Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin. Proc Natl Acad Sci U S A (1988) 0.79

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci U S A (1985) 8.77

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science (1985) 7.99

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol (1985) 7.20

A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem (1982) 6.53

Molecular cloning of the complementary DNA for human tumor necrosis factor. Science (1985) 6.18

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med (1986) 4.99

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A (1983) 3.83

Membrane receptors and hormone action. Adv Protein Chem (1976) 3.73

Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci U S A (1985) 2.92

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci U S A (1985) 2.65

Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem (1985) 2.18

Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15

High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors. J Exp Med (1985) 2.00

The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin. J Immunol (1984) 1.81

Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc Natl Acad Sci U S A (1986) 1.70

Recombinant tumor necrosis factor causes activation of human granulocytes. Blood (1987) 1.62

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer (1984) 1.57

Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jpn J Exp Med (1981) 1.45

Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int J Cancer (1986) 1.45

Subunit structure of a high-affinity receptor for type beta-transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complex. J Biol Chem (1985) 1.28

Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res (1987) 1.17

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Cancer Res (1986) 1.13

Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN. Immunol Lett (1986) 1.06

Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts. J Biol Chem (1985) 1.03

Identification of a receptor for atrial natriuretic factor in rabbit aorta membranes by affinity cross-linking. J Biol Chem (1985) 0.98

Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines. J Immunol (1986) 0.98

Structural characterization of insulin receptors. II. Subunit composition of receptors from turkey erythrocytes. J Biol Chem (1983) 0.89

Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells. Arch Biochem Biophys (1986) 0.87

Demonstration of membrane receptors for human natural and recombinant 125I-labeled tumor necrosis factor on HeLa cell clones and their role in tumor cell sensitivity. Eur J Biochem (1986) 0.84

Articles by these authors

Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet (1992) 7.09

Molecular cloning of the complementary DNA for human tumor necrosis factor. Science (1985) 6.18

Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis (2001) 2.66

Effect of auxin on beta-1, 3-glucanase activity in Avena coleoptile. Dev Growth Differ (1970) 2.10

The Escherichia coli biotin biosynthetic enzyme sequences predicted from the nucleotide sequence of the bio operon. J Biol Chem (1988) 2.00

(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology (2003) 1.82

The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis. Crit Care Med (2001) 1.57

Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer (1999) 1.57

Detection of herpes simplex virus DNA in human tear film by the polymerase chain reaction. Am J Ophthalmol (1994) 1.57

A systematic nerve-sparing radical hysterectomy technique in invasive cervical cancer for preserving postsurgical bladder function. Int J Gynecol Cancer (2005) 1.54

RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer. Genome Res (2000) 1.50

Patterns of internal echoes in lymph nodes in the diagnosis of lung cancer metastasis. World J Surg (1993) 1.47

Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma. J Neurooncol (1990) 1.47

Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science (1989) 1.46

Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res (1996) 1.45

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med (2001) 1.41

beta-d-Glucan of Avena Coleoptile Cell Walls. Plant Physiol (1977) 1.39

Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. Cancer Res (1986) 1.38

Site-specific mutagenesis of the human fibroblast interferon gene. Proc Natl Acad Sci U S A (1984) 1.32

Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol (2001) 1.30

Viscoelastic properties of plant cell walls--I. Mathematical formulation for stress relaxation with consideration for pre-extension rate. Biorheology (1978) 1.30

Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell lines. Proc Natl Acad Sci U S A (1982) 1.29

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood (2000) 1.25

Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol (2001) 1.25

Paralemmin, a prenyl-palmitoyl-anchored phosphoprotein abundant in neurons and implicated in plasma membrane dynamics and cell process formation. J Cell Biol (1998) 1.25

mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol Psychiatry (2007) 1.24

Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci U S A (1980) 1.20

Micelle structure of amelogenin in porcine secretory enamel. J Dent Res (2007) 1.19

Characterization of novel antimicrobial peptoids. Antimicrob Agents Chemother (1999) 1.19

Biological properties of human melanoma cells in culture. In Vitro (1979) 1.18

Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res (1987) 1.17

Herpes simplex esophagitis in the immunocompetent host. Dis Esophagus (2005) 1.15

Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res (1993) 1.14

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Cancer Res (1986) 1.13

Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery. J Thromb Haemost (2006) 1.13

Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Cancer (1986) 1.11

A cDNA encoding a rat mitochondrial cytochrome P450 catalyzing both the 26-hydroxylation of cholesterol and 25-hydroxylation of vitamin D3: gonadotropic regulation of the cognate mRNA in ovaries. DNA Cell Biol (1990) 1.11

Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol (1995) 1.10

Genetic mapping of quantitative trait loci affecting body weight, egg character and egg production in F2 intercross chickens. Anim Genet (2004) 1.09

Pyrrolidine dithiocarbamate inhibits TNF-alpha-dependent activation of NF-kappaB by increasing intracellular copper level in human aortic smooth muscle cells. Biochem Biophys Res Commun (2000) 1.06

Egg transmission of Mycoplasma meleagridis. Poult Sci (1966) 1.03

Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. Oncology (1984) 1.03

Mortality and cancer incidence in patients with Parkinson's disease. J Neurol (2000) 1.01

Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. Gut (1989) 1.00

Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circ Shock (1994) 0.99

Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience (2005) 0.99

Contracture of the deltoid muscle. Results of distal release. J Bone Joint Surg Am (1998) 0.99

Effect of cimetidine on inhibition by tetragastrin of carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res (1988) 0.98

A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer (2000) 0.98

Diabetes mellitus is a multivariate independent prognostic factor in endometrial carcinoma: a clinicopathologic study on 313 patients. Eur J Gynaecol Oncol (2007) 0.98

Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique. Cancer (1992) 0.97

Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats. J Immunother (1991) (1991) 0.97

The structure of the human sterol carrier protein X/sterol carrier protein 2 gene (SCP2). Genomics (1994) 0.96

Cloning and properties of a rice gene encoding phenylalanine ammonia-lyase. Plant Mol Biol (1995) 0.96

Polymerase chain reaction for detection of Mycoplasma gallisepticum. Avian Dis (1991) 0.96

Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. Avian Dis (1987) 0.95

Infectivity of Mycoplasma meleagridis for turkey embryos. Am J Vet Res (1966) 0.95

Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study. J Hypertens (2001) 0.94

Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model. Infect Immun (1993) 0.93

Effects of artificial hair-waving on hair mercury values. Int Arch Occup Environ Health (1978) 0.93

Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14. Blood (1997) 0.93

Diagnosis of gastric cancers with fluorescein-labeled monoclonal antibodies to carcinoembryonic antigen. Lasers Surg Med (1989) 0.93

Effects of alpha- and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma. Biosci Biotechnol Biochem (1995) 0.93

DNA diversity among isolates of Campylobacter jejuni detected by PCR-based RAPD fingerprinting. Vet Microbiol (1995) 0.93

Effects of hypergravity on growth and cell wall properties of cress hypocotyls. J Exp Bot (1996) 0.92

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun (1993) 0.92

Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer. Int J Gynecol Cancer (2003) 0.92

Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase. Mol Cell Biol (1983) 0.92

Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma. Gynecol Oncol (2001) 0.92

Circadian rhythms in the urinary excretion of metals and organic substances in "healthy" men. Arch Environ Health (1984) 0.92

Effects of a new aldose reductase inhibitor on various tissues in vitro. J Pharmacol Exp Ther (1984) 0.92

Concanavalin A-induced receptor aggregation stimulates the tyrosine kinase activity of the insulin receptor in intact cells. Biochem J (1990) 0.91

Empirical growth curve estimation considering multiple seasonal compensatory growths of body weights in Japanese Thoroughbred colts and fillies. J Anim Sci (2013) 0.91

Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. Clin Nephrol (2010) 0.91

Urodynamic study on postsurgical bladder function in cervical cancer treated with systematic nerve-sparing radical hysterectomy. Int J Gynecol Cancer (2006) 0.90

Compression method for measurement of stress-relaxation properties of plant cell walls with reference to plant hormone actions. Biorheology (1981) 0.90

Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor. Cancer (1985) 0.90

Cytologic examination and CEA measurement in aspirated pancreatic material collected by percutaneous fine-needle aspiration biopsy under ultrasonic guidance for the diagnosis of pancreatic carcinoma. Cancer (1983) 0.90

Medical markup language (MML) for XML-based hospital information interchange. J Med Syst (2000) 0.90

Comparison of egg yolk and serum for the detection of Mycoplasma gallisepticum and M. synoviae antibodies by enzyme-linked immunosorbent assay. Avian Dis (1986) 0.89

Pathogenesis of single and mixed infections caused by Mycoplasma meleagridis and Mycoplasma gallisepticum in turkey embryos. Am J Vet Res (1971) 0.89

Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms. J Appl Microbiol (2014) 0.88

Inhibitory effect of progesterone on cell death of mouse uterine epithelium. J Steroid Biochem (1989) 0.88

Architecture for networked electronic patient record systems. Int J Med Inform (2000) 0.88

Recent duplication of the two human CD8 beta-chain genes. J Immunol (1992) 0.88

Modified distribution of methylmercury by additional exposure to elemental mercury or mercuric chloride in mice fed methylmercuric chloride. J Pharmacobiodyn (1980) 0.87

Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass. J Cardiovasc Surg (Torino) (2002) 0.87

Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis. Mol Oral Microbiol (2013) 0.87

Mycoplasma as a cause of canine urinary tract infection. J Am Vet Med Assoc (1984) 0.87

Morphology and growth cycle of Mycoplasma meleagridis viewed by scanning-electron microscopy. Avian Dis (1977) 0.87

Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer (1998) 0.86

Cytohistologic diagnosis of neoplasms of the liver by ultrasonically guided fine-needle aspiration biopsy. Cancer (1984) 0.86

Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials. Cancer (2000) 0.86

Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.86

Development of a shortened Japanese version of the Oral Health Impact Profile (OHIP) for young and middle-aged adults. Community Dent Health (2008) 0.86

Study of edema reduction patterns during the treatment phase of complex decongestive physiotherapy for extremity lymphedema. Lymphology (2008) 0.86

High serum lactate dehydrogenase level predicts short survival after vincristine-doxorubicin-dexamethasone (VAD) salvage for refractory multiple myeloma. Am J Hematol (2000) 0.85